Amy Flaxman Selected Research

asparaginyl-proline

1/2021

Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amy Flaxman Research Topics

Disease

6	Infections 01/2022 - 05/2016
5	COVID-19 10/2022 - 01/2021
4	Malaria 01/2022 - 05/2017
3	Vaccinia 08/2021 - 01/2019
3	Pneumonia (Pneumonitis) 02/2021 - 05/2020
2	Fever (Fevers) 01/2021 - 05/2020
1	Anosmia 01/2021
1	Ageusia (Hypogeusia) 01/2021
1	Cough 01/2021
1	Dyspnea (Shortness of Breath) 01/2021
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2021
1	Human Influenza (Influenza) 03/2019
1	Cross Infection (Nosocomial Infection) 01/2019
1	Abscess 01/2019
1	Meningitis 07/2018
1	Herpes Zoster 07/2018
1	Communicable Diseases (Infectious Diseases) 07/2018
1	Hypersensitivity (Allergy) 05/2017
1	Sepsis (Septicemia) 05/2016
1	Bacteremia 05/2016

Drug/Important Bio-Agent (IBA)

14	VaccinesIBA 07/2022 - 05/2017
8	Proteins (Proteins, Gene)FDA Link 08/2021 - 05/2016
5	ChAdOx1 nCoV-19IBA 07/2022 - 05/2020
3	AntigensIBA 01/2022 - 05/2017
2	Antiviral Agents (Antivirals)IBA 10/2022 - 01/2021
2	Nucleic AcidsIBA 07/2022 - 01/2021
1	Immunoglobulin G (IgG)IBA 01/2022
1	NucleoproteinsIBA 08/2021
1	Influenza Vaccines (Influenza Vaccine)FDA Link 08/2021
1	Combined VaccinesIBA 08/2021
1	asparaginyl-prolineIBA 01/2021
1	Matrix-MIBA 01/2021
1	AntibodiesIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	4CMenB vaccineIBA 07/2018
1	ThrombospondinsIBA 05/2017
1	Tyrosine (L-Tyrosine)FDA Link 05/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 05/2016
1	Transcription Factors (Transcription Factor)IBA 05/2016

Therapy/Procedure

1	Immunotherapy 05/2017